Immune evasion by Staphylococci

被引:865
作者
Foster, TJ [1 ]
机构
[1] Trinity Coll Dublin, Microbiol Dept, Moyne Inst Prevent Med, Dublin 2, Ireland
基金
英国惠康基金;
关键词
D O I
10.1038/nrmicro1289
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Staphylococcus aureus can cause superficial skin infections and, occasionally, deep-seated infections that entail spread through the blood stream. The organism expresses several factors that compromise the effectiveness of neutrophils and macrophages, the first line of defence against infection. S. aureus secretes proteins that inhibit complement activation and neutrophil chemotaxis or that lyse neutrophils, neutralizes antimicrobial defensin peptides, and its cell surface is modified to reduce their effectiveness. The organism can survive in phagosomes, express polysaccharides and proteins that inhibit opsonization by antibody and complement, and its cell wall is resistant to lysozyme. Furthermore, S. aureus expresses several types of superantigen that corrupt the normal humoral immune response, resulting in anergy and immunosuppression. In contrast, Staphylococcus epidermidis must rely primarily on cell-surface polymers and the ability to form a biolfilm to survive in the host.
引用
收藏
页码:948 / 958
页数:11
相关论文
共 134 条
  • [1] ALBER G, 1990, J IMMUNOL, V144, P4501
  • [2] PREDOMINANCE OF 2 NEWLY DESCRIBED CAPSULAR POLYSACCHARIDE TYPES AMONG CLINICAL ISOLATES OF STAPHYLOCOCCUS-AUREUS
    ARBEIT, RD
    KARAKAWA, WW
    VANN, WF
    ROBBINS, JB
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1984, 2 (02) : 85 - 91
  • [3] STAPHYLOCOCCUS-AUREUS MICROCAPSULE EXPRESSION ATTENUATES BACTERIAL VIRULENCE IN A RAT MODEL OF EXPERIMENTAL ENDOCARDITIS
    BADDOUR, LM
    LOWRANCE, C
    ALBUS, A
    LOWRANCE, JH
    ANDERSON, SK
    LEE, JC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (04) : 749 - 753
  • [4] Why are pathogenic staphylococci so lysozyme resistant?: The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus
    Bera, A
    Herbert, S
    Jakob, A
    Vollmer, W
    Götz, F
    [J]. MOLECULAR MICROBIOLOGY, 2005, 55 (03) : 778 - 787
  • [5] Microarray-based analysis of the Staphylococcus aureus σB regulon
    Bischoff, M
    Dunman, P
    Kormanec, J
    Macapagal, D
    Murphy, E
    Mounts, W
    Berger-Bächi, B
    Projan, S
    [J]. JOURNAL OF BACTERIOLOGY, 2004, 186 (13) : 4085 - 4099
  • [6] BOHACH GA, 1999, EXOTOXINS, P367
  • [7] Human α-defensins neutralize fibrinolytic activity exerted by staphylokinase
    Bokarewa, M
    Tarkowski, A
    [J]. THROMBOSIS AND HAEMOSTASIS, 2004, 91 (05) : 991 - 999
  • [8] DIRECT TESTING OF BLOOD CULTURES FOR DETECTION OF THE SEROTYPE-5 AND SEROTYPE-8 CAPSULAR POLYSACCHARIDES OF STAPHYLOCOCCUS-AUREUS
    BOUTONNIER, A
    NATO, F
    BOUVET, A
    LEBRUN, L
    AUDURIER, A
    MAZIE, JC
    FOURNIER, JM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (05) : 989 - 993
  • [9] Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?
    Brogden, KA
    [J]. NATURE REVIEWS MICROBIOLOGY, 2005, 3 (03) : 238 - 250
  • [10] MUTATIONAL ANALYSIS OF THE INTERACTION BETWEEN STAPHYLOCOCCAL PROTEIN-A AND HUMAN IGG(1)
    CEDERGREN, L
    ANDERSSON, R
    JANSSON, B
    UHLEN, M
    NILSSON, B
    [J]. PROTEIN ENGINEERING, 1993, 6 (04): : 441 - 448